Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jayme Franklin"'
Autor:
Minhong Yan, Jayme Franklin, Philip E. Hass, Maciej Paluch, John Brady Ridgway, Jane Ruppel, Siao Ping Tsai, Ryan Cook, Sarajane Ross, Sharon Yee, Gary Cain, Krishna P. Allamneni, Jacqueline Tarrant, Nicholas Lewin-Koh, Amrita V. Kamath, Priyanka Gupta, Christina L. Zuch de Zafra, Joseph C. Beyer, Gu Zhang, Jessica A. Couch
Supplemental Methods: including HUVEC fibrin gel bead assay, Production of anti-DLL4 F(ab')2, Mouse neonatal retina assay, Xenograft tumor models, Histological analysis of mouse liver, PK assay methods, and Anti-therapeutic antibody assay method. Tab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3f0590c39fca49455db48a58b8d59b
https://doi.org/10.1158/1078-0432.22459589
https://doi.org/10.1158/1078-0432.22459589
Autor:
Minhong Yan, Jayme Franklin, Philip E. Hass, Maciej Paluch, John Brady Ridgway, Jane Ruppel, Siao Ping Tsai, Ryan Cook, Sarajane Ross, Sharon Yee, Gary Cain, Krishna P. Allamneni, Jacqueline Tarrant, Nicholas Lewin-Koh, Amrita V. Kamath, Priyanka Gupta, Christina L. Zuch de Zafra, Joseph C. Beyer, Gu Zhang, Jessica A. Couch
Purpose: Although agents targeting Delta-like ligand 4 (DLL4) have shown great promise for angiogenesis-based cancer therapy, findings in recent studies have raised serious safety concerns. To further evaluate the potential for therapeutic targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285f74cb4d522ad9230ef5f64f69dc9d
https://doi.org/10.1158/1078-0432.c.6524255.v1
https://doi.org/10.1158/1078-0432.c.6524255.v1
Autor:
Qi Chen, Kimberly A. Kaleas, H. F. Wang, Amber Bill, Jayme Franklin, Johannes Blümel, Michelle D. Butler, Sally A. Baylis, Bin Yang
Publikováno v:
Biotechnology progressREFERENCES. 36(4)
The contamination of oral rotavirus vaccines by porcine circovirus (PCV) raised questions about potential PCV contamination of other biological products when porcine trypsin or pepsin is used in production process. Several methods can be potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90e86a385b7f4dd3e7f5f10146d4540
https://pubmed.ncbi.nlm.nih.gov/31989781
https://pubmed.ncbi.nlm.nih.gov/31989781
Autor:
Krishna P. Allamneni, Amrita V. Kamath, Siao Ping Tsai, Gu Zhang, Jacqueline M. Tarrant, Jessica Couch, Maciej Paluch, Ryan Cook, Gary Cain, Nicholas Lewin-Koh, Minhong Yan, Christina L. Zuch de Zafra, Jayme Franklin, Sarajane Ross, Philip E. Hass, Joseph Beyer, Jane Ruppel, Priyanka Gupta, Sharon Yee, John B. Ridgway
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(6)
Purpose: Although agents targeting Delta-like ligand 4 (DLL4) have shown great promise for angiogenesis-based cancer therapy, findings in recent studies have raised serious safety concerns. To further evaluate the potential for therapeutic targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8bbb2fa5127325a6941a3699cf5e53
https://pubmed.ncbi.nlm.nih.gov/26589434
https://pubmed.ncbi.nlm.nih.gov/26589434